Related Experiment Videos
Hematopoietic growth factors--an overview.
1Department of Medicine, UCLA School of Medicine 90024-1678.
International Journal of Cell Cloning
|January 1, 1990
Summary
Hematopoietic growth factors, including colony-stimulating factors and interleukins, regulate blood cell production. Optimizing their therapeutic use to enhance host defense holds great potential for treating cancer and infectious diseases.
Area of Science:
- Biochemistry
- Immunology
- Hematology
Background:
- Hematopoietic growth factors are glycoprotein hormones regulating blood cell proliferation and function.
- Numerous colony-stimulating factors and interleukins stimulate blood cell production.
- Many of these factors are produced via recombinant DNA technology and are in clinical trials.
Purpose of the Study:
- To review the current understanding and future potential of hematopoietic growth factors in medicine.
- To highlight the challenge of optimizing the therapeutic application of these factors.
- To emphasize their role in enhancing host defense.
Main Methods:
- Review of scientific literature on hematopoietic growth factors.
- Analysis of current clinical trial data.
- Discussion of future therapeutic strategies.
Main Results:
- A growing list of hematopoietic growth factors is available through recombinant production.
- Most of these factors have entered clinical trials.
- The ability to regulate blood cell numbers and function is rapidly advancing.
Conclusions:
- Hematopoietic growth factors offer the potential to significantly reduce morbidity and mortality.
- Optimizing their use in therapeutic practice is a key challenge for the next decade.
- Enhancing host defense through these factors opens new avenues for treating cancer, infections, and immune deficiencies.